Stress Formula
Natural health product licensed in Canada
- Other names
- Stress Reducer
- Licence holder
- Biomed International Products Corp.
- NPN or DIN-HM
- 80099469
- Status
- Active licence
- Licence date
- 28 April 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Withania somnifera Source : Feuille Potency : 8 % Withanolides | Not specified | Not calculated |
| Withania somnifera Source : Racine Potency : 8 % Withanolides | Not specified | Not calculated |
| Withania somnifera Source : Feuille Potency : 32 % Withania oligosaccharides | Not specified | Not calculated |
| Withania somnifera Source : Racine Potency : 32 % Withania oligosaccharides | Not specified | Not calculated |
| Withania somnifera Source : Feuille Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 1,600 mg Potency : 2 % Withaferin A | 200 mg | Not calculated |
| Withania somnifera Source : Racine Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 1,600 mg Potency : 2 % Withaferin A | 200 mg | Not calculated |
| L-théanine Source : L-Théanine | 100 mg | Not calculated |
| Phosphatidylsérine Source : Phosphatidylserine | 50 mg | Not calculated |
| Magnolia officinalis Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 7:1 Dry plant equivalent : 1,050 mg | 150 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate. Helps reduce cortisol and C-reactive protein levels, the biomarkers of physical stress. Helps to temporarily promote relaxation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80099469
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.